When Fertility Suppression on Testosterone Cypionate Becomes a Reason to Stop

What fertility suppression on cypionate is

Testosterone cypionate is an oil-soluble ester of testosterone given by deep gluteal intramuscular injection for hypogonadism [2]. The Depo-Testosterone label gives a replacement dose of 50 to 400 mg every 2 to 4 weeks and an approximate 8-day half-life after intramuscular injection [2].

The same label explains the mechanism. Exogenous androgens inhibit endogenous testosterone release through feedback inhibition of pituitary luteinizing hormone (LH) and, at large doses, also inhibit follicle stimulating hormone (FSH); sperm production may be suppressed through FSH feedback inhibition, possibly lowering sperm count [2]. The adverse reactions list includes oligospermia at high dosages, without a rate, and the drug abuse section lists testicular atrophy, subfertility and infertility in men who abuse anabolic steroids [2]. The Azmiro (cypionate) and Xyosted (enanthate) labels state that reduced fertility is seen in some men on testosterone replacement and that the effect on fertility may be irreversible.

Fertility situations in which testosterone is questioned

A near-term conception goal is the clearest case. The Endocrine Society recommends against starting testosterone therapy in men planning fertility in the near term [1]. That recommendation is written for starting therapy, not for stopping an existing prescription.

Severe sperm suppression matters when fertility is a goal. In a 2015 retrospective case series, 49 men with azoospermia or severe oligospermia (under 1 million/mL) while on exogenous testosterone were treated with hCG 3,000 units subcutaneously every other day plus clomiphene, tamoxifen, anastrozole or recombinant FSH; spermatogenesis returned or counts improved in 47 (95.9%), with an average time of 4.6 months and a mean first density of 22.6 million/mL [5]. The series did not compare stopping testosterone with continuing it, so it does not show that hCG protects fertility while testosterone continues.

Age and length of exposure change the recovery picture. In a 2017 retrospective study, 66 men with infertility after testosterone use stopped testosterone and received high-dose hCG plus a selective estrogen receptor modulator; 46 (70%) reached a total motile count above 5 million within 12 months [4]. Only 64.8% of azoospermic men reached that threshold, compared with 91.7% of cryptozoospermic men, and older age and longer testosterone use predicted slower recovery [4].

Staying on testosterone with hCG added. In a retrospective review of 26 hypogonadal men who stayed on testosterone (19 on injections, 7 on gel) and added hCG 500 IU every other day, no patient became azoospermic, semen parameters did not change over more than a year of follow-up, and 9 of the 26 men contributed to a pregnancy [6]. It had no comparison group.

What recovery after stopping looks like

The largest recovery dataset comes from hormonal male contraception research, in 1,549 healthy eugonadal men rather than men with hypogonadism, using androgen or androgen-progestin regimens [3]. Median time for sperm concentration to recover to 20 million/mL was 3.4 months; 67% reached that threshold within 6 months, 90% within 12 months, 96% within 16 months and 100% within 24 months [3]. Faster recovery was associated with shorter-acting testosterone, shorter treatment, older age and higher baseline sperm count [3]. Those numbers describe recovery after experimental hormonal suppression, not a promise for cypionate replacement.

The second dataset is clinical recovery after testosterone-related infertility: among 66 men who stopped testosterone and started high-dose hCG plus a SERM, 70% reached a total motile count above 5 million within 12 months, and older age and longer testosterone use predicted slower recovery [4].

Recovery is common across groups and variable within them, and these studies cannot predict an individual man's recovery after stopping testosterone [3][4].

Common questions